Clinical Trial

Effect of Resveratrol Supplementation on Exercise Performance and Recovery

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 9, 2024 (before its estimated April 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
To examine the effects of once daily supplementation with 500mg VeriSperse® resveratrol (VRES) for 17 days on muscle function, delayed onset muscle soreness, systemic concentrations of muscular damage markers and markers of oxidative stress in resistance trained young adult males following a damaging isoinertial squat protocol (ISP).
Trial Details
NCT Number NCT06723119
Lead Sponsor University of Central Florida
Collaborators: Gencor Pacific Group
Conditions Effect of Resveratrol on Performance and Recovery
Enrollment 20 participants
Start Date 2024-10-01
Primary Completion 2025-04-01 (estimated)
Study Completion 2025-04-01 (estimated)
Updated on ClinicalTrials.gov 2024-12-09